Skip to content
zameds

Clonazepam

Sold as Clonam, Clonazepam ascendis, Remialz, Ruslopam, Rivotril

S5
Loading the molecular structure
C15H10ClN3O3315.71 g/mol

5-(2-Chlorophenyl)-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one

Drag to rotate. Structure from PubChem CID 2802.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
6
Registrations
11
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Austell Pharmaceuticals (Pty) LtdClonam0,5, 2450820, 450821S5None
Ascendis Pharma (Pty) LtdClonazepam ascendis0,5, 2450822, 450823S5None
Pharmacare limited û woodmeadRemialz0,5 mg, 2 mg540699, 540700S5None
Lebasi Pharmaceuticals (Pty) LtdRuslopam1 mg590126S5PIPIL
Pharmaco Distribution (Pty) LtdRivotril0,5 mg, 1 mg/ml, 2 mgF0187, F0189, F0190S5None
Roche Products (Pty) LtdRivotril2,5 mg/mlF0188S5None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Clonam 0,5

EACH TABLET CONTAINS :CLONAZEPAM 0,5 mg

0,545082045/2.5/0820RegisteredS5None
Clonam 2

EACH TABLET CONTAINS :CLONAZEPAM 2,0 mg

245082145/2.5/0821RegisteredS5None
Clonazepam 0,5 ascendis

EACH TABLET CONTAINS CLONAZEPAM 0,5 mg

0,545082245/2.5/0822RegisteredS5None
Clonazepam 2 ascendis

EACH TABLET CONTAINS CLONAZEPAM 2,0 mg

245082345/2.5/0823RegisteredS5None
Remialz 0,5 MG tablets

EACH TABLET CONTAINS CLONAZEPAM 0,5 mg

0,5 mgTablets54069954/2.5/0699RegisteredS5None
Remialz 2 MG tablets

EACH TABLET CONTAINS CLONAZEPAM 2,0 mg

2 mgTablets54070054/2.5/0700RegisteredS5None
Ruslopam 1 mg/ml

EACH 1,0 ml SOLUTION CONTAINS: CLONAZEPAM 1,0 mg

1 mgConcentrate for solution for injection/infusion59012659/2.5/0126Approved 14 July 2026RegisteredS5PIPIL
Rivotril 1 mg/ml ampoules

EACH 1 ml SOLUTION CONTAINS CLONAZEPAM 1 mg

1 mg/mlAmpoulesF0187F/2.5/187RegisteredS5None
Rivotril 2,5 mg/ml drops

EACH 1 ml SOLUTION CONTAINS CLONAZEPAM 2,5 mg

2,5 mg/mlDropsF0188F/2.5/188RegisteredS5None
Rivotril 0,5 MG

EACH TABLET CONTAINS CLONAZEPAM 0,5 mg

0,5 mgF0189F/2.5/189RegisteredS5None
Rivotril 2 MG tablets

EACH TABLET CONTAINS CLONAZEPAM 2 mg

2 mgTabletsF0190F/2.5/190RegisteredS5None

Regulatory status

Where S5 sits on the scale

Prescription-only, with tighter controls on repeats.

Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.

Consolidated Schedules listings for Clonazepam

  • S5: Clonazepam

    Consolidated Schedules 06 July 2026, line 9333

Pharmacological class: Anticonvulsants, including anti-epileptics. (class 2.5)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Ruslopam 1 mg/ml, Lebasi Pharmaceuticals (Pty) Ltd is scheduled S5 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsRuslopam 1 mg/ml, Lebasi Pharmaceuticals (Pty) LtdPatient information leaflet (PIL)For patients and carersRuslopam 1 mg/ml, Lebasi Pharmaceuticals (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles